Inhibition of estradiol synthesis attenuates renal injury in male streptozotocin-induced diabetic rats

American Journal of Physiology - Renal Physiology

Volumn 301, Issue 3, 2011, Pages

  Manigrasso, Michaele B ^a   Sawyer, R Taylor ^a   Marbury, David C ^a   Flynn, Elizabeth R ^a   Maric, Christine ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetes; Estrogen; Testosterone

Indexed keywords

ALBUMIN; ANASTROZOLE; COLLAGEN TYPE 4; ESTRADIOL; INTERLEUKIN 6; TESTOSTERONE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DENSITY; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; ESTROGEN SYNTHESIS; GLOMERULOSCLEROSIS; INTERSTITIAL NEPHRITIS; KIDNEY CORTEX; KIDNEY INJURY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; STREPTOZOCIN DIABETES; TESTOSTERONE BLOOD LEVEL; URINALYSIS; URINARY EXCRETION;

EID: 80052410207     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00718.2010     Document Type: Article

References (35)

1. Aizawa K, Iemitsu M, Maeda S, Jesmin S, Otsuki T, Mowa CN, Miyauchi T, Mesaki N. Expression of steroidogenic enzymes and synthesis of sex steroid hormones from DHEA in skeletal muscle of rats. Am J Physiol Endocrinol Metab 292: E577-E584, 2007.
2. Antus B, Hamar P, Kokeny G, Szollosi Z, Mucsi I, Nemes Z, Rosivall L. Estradiol is nephroprotective in the rat remnant kidney. Nephrol Dial Transplant 18: 54-61, 2003.
3. Christeff N, Auclair MC, Dehennin L, Thobie N, Benassayag C, Carli A, Nunez EA. Effect of the aromatase inhibitor, 4 hydroxyandrostenedione, on the endotoxin-induced changes in steroid hormones in male rats. Life Sci 50: 1459-1468, 1992.
4. Dalla Valle L, Toffolo V, Vianello S, Belvedere P, Colombo L. Expression of cytochrome P450scc mRNA and protein in the rat kidney from birth to adulthood. J Steroid Biochem Mol Biol 88: 79-89, 2004.
5. Dukes M, Edwards PN, Large M, Smith IK, Boyle T. The preclinical pharmacology of "Arimidex" (anastrozole; ZD1033)-a potent, selective aromatase inhibitor. J Steroid Biochem Mol Biol 58: 439-445, 1996.
6. Geisler J, King N, Dowsett M, Ottestad L, Lundgren S, Walton P, Kormeset PO, Lonning PE. Influence of anastrozole (Arimidex), a selective, nonsteroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancer. Br J Cancer 74: 1286-1291, 1996.
7. Gilliver SC, Emmerson E, Campbell L, Chambon P, Hardman MJ, Ashcroft GS. 17β-Estradiol inhibits wound healing in male mice via estrogen receptor-α. Am J Pathol 176: 2707-2721, 2010.
8. Grossmann M, Panagiotopolous S, Sharpe K, MacIsaac RJ, Clarke S, Zajac JD, Jerums G, Thomas MC. Low testosterone and anaemia in men with type 2 diabetes. Clin Endocrinol (Oxf) 70: 547-553, 2009.
9. Grossmann M, Thomas MC, Panagiotopoulos S, Sharpe K, Macisaac RJ, Clarke S, Zajac JD, Jerums G. Low testosterone levels are common and associated with insulin resistance in men with diabetes. J Clin Endocrinol Metab 93: 1834-1840, 2008.
10. Ho J, Ng KH, Rosen S, Dostal A, Gregory RI, Kreidberg JA. Podocytespecific loss of functional microRNAs leads to rapid glomerular and tubular injury. J Am Soc Nephrol 19: 2069-2075, 2008.
11. Joles JA, van Goor H, Koomans HA. Estrogen induces glomerulosclerosis in analbuminemic rats. Kidney Int 53: 862-868, 1998.
12. Kasimay O, Sener G, Cakir B, Yuksel M, Cetinel S, Contuk G, Yegen BC. Estrogen protects against oxidative multiorgan damage in rats with chronic renal failure. Ren Fail 31: 711-725, 2009.
13. Kumru S, Yildiz AA, Yilmaz B, Sandal S, Gurates B. Effects of aromatase inhibitors letrozole and anastrazole on bone metabolism and steroid hormone levels in intact female rats. Gynecol Endocrinol 23: 556-561, 2007.
14. Lephart ED, Lund TD, Horvath TL. Brain androgen and progesterone metabolizing enzymes: biosynthesis, distribution and function. Brain Res Brain Res Rev 37: 25-37, 2001.
15. Longcope C, Pratt JH. Blood production rates of estrogens in women with differing ratios of urinary estrogen conjugates. Steroids 29: 483-492, 1977.
16. Mankhey RW, Bhatti F, Maric C. 17β-Estradiol replacement improves renal function and pathology associated with diabetic nephropathy. Am J Physiol Renal Physiol 288: F399-F405, 2005.
17. Mankhey RW, Wells CC, Bhatti F, Maric C. 17β-Estradiol supplementation reduces tubulointerstitial fibrosis by increasing MMP activity in the diabetic kidney. Am J Physiol Regul Integr Comp Physiol 292: R769-R777, 2007.
18. Maric C, Forsblom C, Thorn L, Waden J, Groop PH. Association between testosterone, estradiol and sex hormone binding globulin levels in men with type 1 diabetes with nephropathy. Steroids 75: 772-778, 2010.
19. Matsushita M, Tamura K, Osada S, Kogo H. Effect of troglitazone on the excess testosterone and LH secretion in thyroidectomized, insulinresistant, type 2 diabetic Goto-Kakizaki rats. Endocrine 27: 301-305, 2005.
20. May LT, Shaw JE, Khanna AK, Zabriskie JB, Sehgal PB. Marked cell-type-specific differences in glycosylation of human interleukin-6. Cytokine 3: 204-211, 1991.
21. Neugarten J. Gender and the progression of renal disease. J Am Soc Nephrol 13: 2807-2809, 2002.
22. Plourde PV, Dyroff M, Dukes M. Arimidex: a potent and selective fourth-generation aromatase inhibitor. Breast Cancer Res Treat 30: 103-111, 1994.
23. Prabhu A, Xu Q, Manigrasso MB, Biswas M, Flynn E, Iliescu R, Lephart ED, Maric C. Expression of aromatase, androgen and estrogen receptors in peripheral target tissues in diabetes. Steroids 75: 779-787, 2010.
24. Qian Y, Feldman E, Pennathur S, Kretzler M, Brosius FC 3rd. From fibrosis to sclerosis: mechanisms of glomerulosclerosis in diabetic nephropathy. Diabetes 57: 1439-1445, 2008.
25. Quinkler M, Diederich S, Bahr V, Oelkers W. The role of progesterone metabolism and androgen synthesis in renal blood pressure regulation. Horm Metab Res 36: 381-386, 2004.
26. Reddy GR, Kotlyarevska K, Ransom RF, Menon RK. The podocyte and diabetes mellitus: is the podocyte the key to the origins of diabetic nephropathy? Curr Opin Nephrol Hypertens 17: 32-36, 2008.
27. Salonia A, Lanzi R, Scavini M, Pontillo M, Gatti E, Petrella G, Licata G, Nappi RE, Bosi E, Briganti A, Rigatti P, Montorsi F. Sexual function and endocrine profile in fertile women with type 1 diabetes. Diabetes Care 29: 312-316, 2006.
28. Schneider CP, Nickel EA, Samy TS, Schwacha MG, Cioffi WG, Bland KI, Chaudry IH. The aromatase inhibitor, 4-hydroxyandrostenedione, restores immune responses following trauma-hemorrhage in males and decreases mortality from subsequent sepsis. Shock 14: 347-353, 2000.
29. Silbiger SR, Neugarten J. The impact of gender on the progression of chronic renal disease. Am J Kidney Dis 25: 515-533, 1995.
30. Simpson ER, Zhao Y, Agarwal VR, Michael MD, Bulun SE, Hinshelwood MM, Graham-Lorence S, Sun T, Fisher CR, Qin K, Mendelson CR. Aromatase expression in health and disease. Recent Prog Horm Res 52: 185-213, 1997.
31. Somlo S, Mundel P. Getting a foothold in nephrotic syndrome. Nat Genet 24: 333-335, 2000.
32. Thorner PS, Ho M, Eremina V, Sado Y, Quaggin S. Podocytes contribute to the formation of glomerular crescents. J Am Soc Nephrol 19: 495-502, 2008.
33. Vikan T, Schirmer H, Njolstad I, Svartberg J. Low testosterone and sex hormone-binding globulin levels and high estradiol levels are independent predictors of type 2 diabetes in men. Eur J Endocrinol 162: 747-754, 2010.
34. Xu Q, Prabhu A, Xu S, Manigrasso MB, Maric C. Dose-dependent effects of dihydrotestosterone in the streptozotocin-induced diabetic rat kidney. Am J Physiol Renal Physiol 297: F307-F315, 2009.
35. Xu Q, Wells CC, Garman JH, Asico L, Escano CS, Maric C. Imbalance in sex hormone levels exacerbates diabetic renal disease. Hypertension 51: 1218-1224, 2008.